Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Mahesh V. Madhavan, Behnood Bikdeli, Aakriti Gupta, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 07, pp. 1004-1024
Open Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Post-acute COVID-19 syndrome
Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 601-615
Open Access | Times Cited: 4248
Extrapulmonary manifestations of COVID-19
Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1017-1032
Open Access | Times Cited: 3022
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost, et al.
JAMA (2021) Vol. 325, Iss. 16, pp. 1620-1620
Open Access | Times Cited: 591
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
David Jiménez, Aldara García‐Sánchez, Parth Rali, et al.
CHEST Journal (2020) Vol. 159, Iss. 3, pp. 1182-1196
Open Access | Times Cited: 424
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Toshiaki Iba, Jean M. Connors, Jerrold H. Levy
Inflammation Research (2020) Vol. 69, Iss. 12, pp. 1181-1189
Open Access | Times Cited: 403
COVID-19: from an acute to chronic disease? Potential long-term health consequences
Victoria Higgins, Dorsa Sohaei, Eleftherios P. Diamandis, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 58, Iss. 5, pp. 297-310
Closed Access | Times Cited: 376
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 020-047
Open Access | Times Cited: 363
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Coraline Radermecker, Nancy Detrembleur, Julien Guiot, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 12
Open Access | Times Cited: 324
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19
Gregory Piazza, Umberto Campia, Shelley Hurwitz, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 18, pp. 2060-2072
Open Access | Times Cited: 269
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
Aakriti Gupta, Mahesh V. Madhavan, Timothy J. Poterucha, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 176
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses
Nigel Mackman, Silvio Antoniak, Alisa S. Wolberg, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 9, pp. 2033-2044
Open Access | Times Cited: 170
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
Grigoris T. Gerotziafas, M. Catalano, Mary Paula Colgan, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 12, pp. 1597-1628
Open Access | Times Cited: 169
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 15, pp. 1903-1921
Open Access | Times Cited: 164
Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, et al.
Journal of the American Heart Association (2020) Vol. 10, Iss. 3
Open Access | Times Cited: 162
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
R. Alon, Mike Sportiello, Stav Kozlovski, et al.
Nature reviews. Immunology (2020) Vol. 21, Iss. 1, pp. 49-64
Open Access | Times Cited: 159
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista Poderoso, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 119
Anti-Xa activity below range is related to thrombosis in patients with severe COVID-19
Pilar Marcos-Neira, Cristian Morales‐Indiano, Mariana Fernández‐Caballero, et al.
Medicina Intensiva (2025) Vol. 49, Iss. 2, pp. 78-87
Closed Access | Times Cited: 1
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients
B. Mouhat, Matthieu Besutti, Kévin Bouiller, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 4, pp. 2001811-2001811
Open Access | Times Cited: 130
Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
Artur Słomka, Mariusz Kowalewski, Ewa Żekanowska
Pathogens (2020) Vol. 9, Iss. 6, pp. 493-493
Open Access | Times Cited: 99
Venous Thromboembolism in COVID-19
Sam Schulman, Yu Hu, Stavros Konstantinides
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 12, pp. 1642-1653
Open Access | Times Cited: 85
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype
Dario Bongiovanni, Melissa Klug, Olga Lazareva, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 85
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, et al.
Thrombosis Research (2020) Vol. 196, pp. 382-394
Open Access | Times Cited: 84
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Choongho Lee, Won Jun Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 99-116
Open Access | Times Cited: 83
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Giulio Francesco Romiti, Bernadette Corica, Gregory Y.H. Lip, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2490-2490
Open Access | Times Cited: 79
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Uttpal Anand, Shweta Jakhmola, Omkar Indari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top